Enovix (NASDAQ:ENVX – Free Report) had its price target reduced by Canaccord Genuity Group to $2.50 in a research note released on Monday,Benzinga reports. They currently have a buy rating on the stock.
ENVX has been the subject of several other reports. Cantor Fitzgerald reiterated an “overweight” rating and set a $20.00 price target on shares of Enovix in a report on Thursday, August 13th. TD Cowen raised Enovix to a “hold” rating in a report on Monday, October 5th. B. Riley Financial downgraded Enovix from a “buy” rating to a “neutral” rating and cut their price objective for the company from $9.00 to $2.00 in a report on Friday, November 13th. Weiss Ratings restated a “sell (e+)” rating on shares of Enovix in a research report on Friday, October 2nd. Finally, Loop Capital raised Enovix to a “strong-buy” rating in a report on Monday, August 17th. One equities research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating, five have assigned a Hold rating and three have given a Sell rating to the stock. Based on data from MarketBeat.com, Enovix has a consensus rating of “Hold” and a consensus price target of $6.95.
Get Our Latest Analysis on Enovix
Enovix Price Performance
ENVX stock opened at $1.48 on Monday. The company has a 50 day simple moving average of $2.16 and a 200 day simple moving average of $3.86. The stock has a market cap of $314.07 million, a price-to-earnings ratio of -2.03 and a beta of 2.34. Enovix has a 1 year low of $1.27 and a 1 year high of $9.19. The company has a debt-to-equity ratio of 3.05, a current ratio of 9.10 and a quick ratio of 9.37.
Enovix (NASDAQ:ENVX – Get Free Report) last issued its quarterly earnings data on Friday, November 13th. The company reported ($0.15) EPS for the quarter, beating the consensus estimate of ($0.20) by $0.05. Enovix had a negative net margin of 406.54% and a negative return on equity of 73.21%. The business had revenue of $11.04 million during the quarter. Research analysts anticipate that Enovix will post -0.79 EPS for the current fiscal year.
Institutional Investors Weigh In On Enovix
Several hedge funds have recently added to or reduced their stakes in the business. BlackRock Inc. acquired a new position in Enovix in the 2nd quarter valued at approximately $100,054,000. Goldman Sachs Group Inc. raised its stake in shares of Enovix by 22.0% during the third quarter. Goldman Sachs Group Inc. now owns 2,038,868 shares of the company’s stock valued at $5,913,000 after acquiring an additional 368,066 shares during the last quarter. Jump Financial LLC raised its stake in shares of Enovix by 185.1% during the third quarter. Jump Financial LLC now owns 1,596,042 shares of the company’s stock valued at $4,629,000 after acquiring an additional 1,036,189 shares during the last quarter. Connor Clark & Lunn Investment Management Ltd. acquired a new position in shares of Enovix during the second quarter worth $8,689,000. Finally, Bank of America Corp DE acquired a new position in shares of Enovix during the second quarter worth $8,356,000. 50.92% of the stock is currently owned by institutional investors and hedge funds.
Enovix Company Profile
Enovix Corporation develops lithium-ion batteries using a silicon-based anode and a proprietary three-dimensional cell architecture. Its design is intended to increase energy density while addressing safety and performance requirements in compact devices. The company’s batteries are designed for applications including smartphones, wearable devices, laptops, augmented- and virtual-reality products, and other portable electronics. Enovix also targets markets such as defense and industrial technology.
Recommended Stories
- Five stocks we like better than Enovix
- Drilling for Yield in the Gulf: Chevron Drops Anchor in Deepwater
- TJX Stock Flashes a Strong Bullish Signal as Its $3 Billion Buyback Plan Takes Shape
- Viking’s Low-Water Miss Looks Like a Buy-the-Dip Opportunity
- Why Amazon Wants the Chips and Blackstone Wants the Buildings
Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.
